Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex vs Neostigmine for NMB reversal in kidney transplant
NCT03923556Phase 4Completed
- Sponsor
- University of Colorado Denver
- Start
- Feb 2021
- Primary completion
- Sep 2023
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Sugammadex in Postoperative residual curarization (PORC), sponsored by University of Colorado Denver. Primary endpoint: Number of Patients With Hypoventilation in PACU at 3 hours. Started Feb 2021; status: completed.
02
Drugs
Sugammadex
03
Conditions
Postoperative residual curarization (PORC)
Beyond the preview
Go deeper on NCT03923556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03923556.